Does TILDRAKIZUMAB-ASMN Cause Peripheral swelling? 8 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Peripheral swelling have been filed in association with TILDRAKIZUMAB-ASMN. This represents 0.5% of all adverse event reports for TILDRAKIZUMAB-ASMN.
8
Reports of Peripheral swelling with TILDRAKIZUMAB-ASMN
0.5%
of all TILDRAKIZUMAB-ASMN reports
0
Deaths
1
Hospitalizations
How Dangerous Is Peripheral swelling From TILDRAKIZUMAB-ASMN?
Of the 8 reports, 1 (12.5%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Peripheral swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TILDRAKIZUMAB-ASMN. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does TILDRAKIZUMAB-ASMN Cause?
Product dose omission issue (363)
Drug ineffective (223)
Psoriasis (86)
Death (84)
Product storage error (74)
Self-medication (74)
Off label use (66)
Condition aggravated (63)
Rash (54)
Pruritus (52)
What Other Drugs Cause Peripheral swelling?
ADALIMUMAB (13,837)
ETANERCEPT (12,654)
METHOTREXATE (10,632)
TOCILIZUMAB (8,030)
TOFACITINIB (7,830)
ABATACEPT (7,561)
LEFLUNOMIDE (7,254)
LENALIDOMIDE (6,364)
HYDROXYCHLOROQUINE (6,128)
RITUXIMAB (5,977)
Which TILDRAKIZUMAB-ASMN Alternatives Have Lower Peripheral swelling Risk?
TILDRAKIZUMAB-ASMN vs TILIDINE
TILDRAKIZUMAB-ASMN vs TIMOLOL
TILDRAKIZUMAB-ASMN vs TIMOLOL\TRAVOPROST
TILDRAKIZUMAB-ASMN vs TINIDAZOLE
TILDRAKIZUMAB-ASMN vs TINZAPARIN